These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3878608)

  • 41. Platelet receptors for human Factor VIII/von Willebrand protein: functional correlation of receptor occupancy and ristocetin-induced platelet aggregation.
    Kao KJ; Pizzo SV; McKee PA
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5317-20. PubMed ID: 315561
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proceedings: Interaction of ristocetin (R), von Willebrand factor (vWF), factor VIII clotting activity (VIIIc) and platelets.
    Zucker MB; McPherson J; Kim SJ; Macdonald VE; Taylor D; Johnson AJ; Barlow GH
    Thromb Diath Haemorrh; 1975 Nov; 34(2):582. PubMed ID: 1081748
    [No Abstract]   [Full Text] [Related]  

  • 43. A monoclonal antibody to the surface membrane of human platelets which inhibits ristocetin- and collagen-induced platelet aggregation reacts with H1 histones of cell nuclei.
    Cosgrove L; Alderuccio F; Toh BH; Pedersen J; Holliday A; McKenzie I
    Clin Exp Immunol; 1987 Aug; 69(2):409-19. PubMed ID: 3308229
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased shear stress- and ristocetin-induced binding of von Willebrand factor to platelets in cord compared with adult plasma.
    Rehak T; Cvirn G; Gallistl S; Leschnik B; Köstenberger M; Katzer H; Ribitsch V; Muntean W
    Thromb Haemost; 2004 Oct; 92(4):682-7. PubMed ID: 15467896
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Von Willebrand factor in the vessel wall mediates platelet adherence.
    Stel HV; Sakariassen KS; de Groot PG; van Mourik JA; Sixma JJ
    Blood; 1985 Jan; 65(1):85-90. PubMed ID: 3917314
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Two novel anti-von Willebrand factor monoclonal antibodies.
    Spadafora-Ferreira M; Lopes AA; Coelho V; Guilherme L; Kalil J
    Thromb Res; 2000 Jan; 97(2):3-13. PubMed ID: 10688330
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ristocetin and von Willebrand factor analysis.
    Light J; Williams CE; Entwistle MB
    Med Lab Sci; 1987 Jul; 44(3):272-9. PubMed ID: 3501515
    [No Abstract]   [Full Text] [Related]  

  • 48. Interaction of von Willebrand factor with human platelets in the plasma milieu.
    Schullek J; Jordan J; Montgomery RR
    J Clin Invest; 1984 Feb; 73(2):421-8. PubMed ID: 6230372
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acquired von Willebrand disease due to inhibitor of human myeloma protein specific for von Willebrand factor.
    Mohri H; Noguchi T; Kodama F; Itoh A; Ohkubo T
    Am J Clin Pathol; 1987 May; 87(5):663-8. PubMed ID: 3107370
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hybridoma antibodies to human von Willebrand factor. II. Relative role of intramolecular loci in mediation of platelet adhesion to the subendothelium.
    Meyer D; Baumgartner HR; Edginton TS
    Br J Haematol; 1984 Aug; 57(4):609-20. PubMed ID: 6204681
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fine mapping of monoclonal antibody epitopes on human von Willebrand factor using a recombinant peptide library.
    Ginsburg D; Bockenstedt PL; Allen EA; Fox DA; Foster PA; Ruggeri ZM; Zimmerman TS; Montgomery RR; Bahou WF; Johnson TA
    Thromb Haemost; 1992 Jan; 67(1):166-71. PubMed ID: 1377414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heparin inhibition of von Willebrand factor-dependent platelet function in vitro and in vivo.
    Sobel M; McNeill PM; Carlson PL; Kermode JC; Adelman B; Conroy R; Marques D
    J Clin Invest; 1991 May; 87(5):1787-93. PubMed ID: 2022745
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of receptors for fibrinogen and von Willebrand factor mediating aggregation in guinea pig platelets.
    Kupinski JM; Miller JL
    Thromb Res; 1986 Aug; 43(3):335-44. PubMed ID: 3016944
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Von Willebrand factor-dependent agglutination of washed fixed human platelets by insoluble collagen isolated from bovine aorta.
    Perret BA; Furlan M; Jenö P; Beck EA
    J Lab Clin Med; 1986 Mar; 107(3):244-52. PubMed ID: 3005453
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proteolytic and immunologic comparison of human and bovine von Willebrand factor.
    Bakhshi MR; Kirby EP
    Thromb Haemost; 1990 Jun; 63(3):517-23. PubMed ID: 2205950
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Investigation of the role of von Willebrand factor in thrombotic thrombocytopenic purpura.
    Lian EC; Siddiqui FA
    Blood; 1985 Nov; 66(5):1219-21. PubMed ID: 3876857
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Platelet factor 4 does not promote von Willebrand factor binding to human platelets.
    Levine SP; Moake JL
    Thromb Res; 1984 Nov; 36(3):233-43. PubMed ID: 6440307
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A paradoxical effect of antibody concentration on vWF-dependent platelet agglutination distinguishes between botrocetin and ristocetin-induced agglutination.
    Roberson DW; Upchurch GR; Lamb MA; Read MS; Wagner RH; Cooper HA
    Thromb Res; 1986 Dec; 44(6):749-60. PubMed ID: 3492062
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monoclonal antibodies against human factor VIII molecular neutralize antihemophilic factor and ristocetin cofactor activities.
    Sola B; Avner P; Sultan Y; Jeanneau C; Maisonneuve P
    Proc Natl Acad Sci U S A; 1982 Jan; 79(1):183-7. PubMed ID: 6798569
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Actions of ristocetin on platelets.
    Koutts J; Stott L; Firkin BG
    Am J Hematol; 1976; 1(3):313-7. PubMed ID: 1087117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.